These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7685817)

  • 1. The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement.
    Potyk DK; Tabbarah HJ
    J Gen Intern Med; 1993 Apr; 8(4):213-9. PubMed ID: 7685817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of low-dose heparin--warfarin anticoagulation prophylaxis after total hip replacement arthroplasty.
    Goss TP; Stinchfield FE; Cosgriff SW
    Clin Orthop Relat Res; 1979 Jun; (141):134-7. PubMed ID: 477094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
    Dranitsaris G; Stumpo C; Smith R; Bartle W
    Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement.
    Francis CW; Pellegrini VD; Marder VJ; Totterman S; Harris CM; Gabriel KR; Azodo MV; Leibert KM
    JAMA; 1992 Jun; 267(21):2911-5. PubMed ID: 1583760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
    Imperiale TF; Speroff T
    JAMA; 1994 Jun; 271(22):1780-5. PubMed ID: 7515115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement.
    Paiement G; Wessinger SJ; Waltman AC; Harris WH
    J Arthroplasty; 1987; 2(1):23-6. PubMed ID: 3572408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin.
    Woolson ST; Watt JM
    J Bone Joint Surg Am; 1991 Apr; 73(4):507-12. PubMed ID: 2013589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee replacement.
    Francis CW; Pellegrini VD; Harris CM; Marder VJ
    Am J Med; 1989 Sep; 87(3B):61S-66S. PubMed ID: 2478015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.
    Menzin J; Colditz GA; Regan MM; Richner RE; Oster G
    Arch Intern Med; 1995 Apr; 155(7):757-64. PubMed ID: 7695464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran.
    Verstraete M
    Surg Gynecol Obstet; 1976 Dec; 143(6):981-5. PubMed ID: 996722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of prophylaxis on proximal venous thrombus formation after total hip arthroplasty.
    Paiement GD; Schutzer SF; Wessinger SJ; Harris WH
    J Arthroplasty; 1992 Dec; 7(4):471-5. PubMed ID: 1282537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
    Epstein NE
    Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement.
    Barber HM; Feil EJ; Galasko CS; Edwards DH; Sutton RA; Haynes DW; Bentley G
    Postgrad Med J; 1977 Mar; 53(617):130-3. PubMed ID: 859784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of prophylaxis in total hip replacement.
    Paiement GD; Wessinger SJ; Harris WH
    Am J Surg; 1991 Apr; 161(4):519-24. PubMed ID: 1903606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis against venous thromboembolism in orthopedic surgery.
    Liu LT; Ma BT
    Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.